Korro Bio (KRRO) Capital Expenditures (2018 - 2026)
Korro Bio (KRRO) posted Capital Expenditures of $21000.0 for Q1 2026, down 75.0% on a QoQ basis from $84000.0 in Q4 2025, and down 82.35% year-over-year from $119000.0 in Q1 2025.
Korro Bio (KRRO) Capital Expenditures (2018 - 2026) Analysis & Trends
Korro Bio's Capital Expenditures history runs 9 years deep, the most recent figure standing at $21000.0 for Q1 2026.
- Quarterly Capital Expenditures fell 82.35% year-over-year to $21000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $420000.0 (down 96.62% YoY) and the FY2025 annual result came in at $518000.0, down 97.11% from the prior year.
- Capital Expenditures was $21000.0 for Q1 2026 at Korro Bio, down from $84000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $6.0 million in Q2 2024 and bottomed at -$16000.0 in Q3 2022.
- A 5-year average of $1.8 million and a median of $246000.0 in 2023 frame the typical range for Capital Expenditures.
- Annual changes were most pronounced in 2022 — Capital Expenditures plunged 100.76% — and 2023, when it surged 110450.0%.
- Korro Bio's Capital Expenditures stood at $5.1 million in 2022, then tumbled by 67.78% to $1.7 million in 2023, then declined by 12.27% to $1.5 million in 2024, then plunged by 94.21% to $84000.0 in 2025, then plunged by 75.0% to $21000.0 in 2026.
- Business Quant data shows KRRO's Capital Expenditures at $21000.0 in Q1 2026, $84000.0 in Q4 2025, and $175000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 43.25 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 786,000.00 |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - | 21,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21,000.00 |
| Mar 31, 2026 | 21,000.00 |
| Dec 31, 2025 | 84,000.00 |
| Dec 31, 2025 | 84,000.00 |
| Sep 30, 2025 | 175,000.00 |
| Sep 30, 2025 | 175,000.00 |
| Jun 30, 2025 | 140,000.00 |
| Jun 30, 2025 | 140,000.00 |
| Mar 31, 2025 | 119,000.00 |
| Mar 31, 2025 | 119,000.00 |
| Dec 31, 2024 | 1.45 Mn |
| Dec 31, 2024 | 1.45 Mn |
| Sep 30, 2024 | 4.88 Mn |
| Sep 30, 2024 | 4.88 Mn |
| Jun 30, 2024 | 5.96 Mn |
| Jun 30, 2024 | 5.96 Mn |
| Mar 31, 2024 | 5.61 Mn |
| Mar 31, 2024 | 5.61 Mn |
| Dec 31, 2023 | 1.66 Mn |
| Dec 31, 2023 | 1.66 Mn |